2025
SJR Q1
JCR Q1 · 5,6
5 matched articles
SCIE
Journal detail
Critical Reviews in Toxicology
- Publisher
- Taylor and Francis Ltd.
- Country
- United Kingdom · Western Europe
- Type
- journal
- ISSN
-
1040844415476898
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 1,302
- Quartile Q1
- H-Index 139
- Cites/doc 6,03
- Docs (3y) 113
- Cites (3y) 672
Clarivate
Web of Science · JCR · 2025
- JCR Q Q1
- JIF 5,6
- 5Y JIF 6,9
- JCI 0,65
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Toxicology Q1
Areas
- Pharmacology, Toxicology and Pharmaceutics
WoS categories
- Toxicology
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q1 | 1,302 | 5,6 | 6,9 | 0,65 | Q3 | 139 |
| 2024 | Q1 | Q1 | 1,147 | 4,1 | 5,9 | 0,63 | Q3 | 134 |
| 2023 | Q1 | Q1 | 1,18 | 5,7 | 7,6 | 0,76 | Q2 | 134 |
| 2022 | Q1 | Q1 | 1,007 | 5,9 | 6,2 | 0,77 | Q2 | 134 |
| 2021 | Q1 | Q1 | 1,111 | 6,2 | 6,7 | 0,78 | Q2 | 134 |
| 2020 | Q1 | Q1 | 1,092 | 5,6 | 6,6 | 0,7 | Q3 | 134 |
| 2019 | Q1 | Q1 | 1,107 | 4,3 | 5,5 | 0,83 | Q2 | 134 |
| 2018 | — | Q1 | — | 4,8 | 6 | 0,9 | Q2 | — |
| 2017 | Q1 | Q1 | 1,828 | 5,3 | 6,1 | 0,97 | Q2 | 134 |
| 2016 | Q1 | Q1 | 1,809 | 5,2 | 5,8 | — | — | 134 |
| 2015 | Q1 | Q1 | 1,806 | 5,4 | 5,9 | — | — | 134 |
| 2014 | Q1 | Q1 | 1,664 | 5,1 | 6,1 | — | — | 134 |
| 2013 | Q1 | Q1 | 1,948 | 6,4 | 6,3 | — | — | 134 |
| 2012 | Q1 | Q1 | 2,025 | 6,3 | 6 | — | — | 134 |
| 2011 | Q1 | Q1 | 1,939 | 5,2 | 6,2 | — | — | 134 |
| 2010 | Q1 | Q1 | 1,546 | 4 | 6,2 | — | — | 134 |
| 2009 | — | Q1 | — | 4,2 | 6,5 | — | — | — |
| 2008 | — | Q1 | — | 7,2 | 7,5 | — | — | — |
| 2007 | — | Q1 | — | 5,1 | 6,1 | — | — | — |
| 2006 | — | Q1 | — | 3,7 | — | — | — | — |
| 2005 | — | Q1 | — | 5 | — | — | — | — |
| 2004 | — | Q1 | — | 3,5 | — | — | — | — |
| 2003 | — | Q1 | — | 2,5 | — | — | — | — |
| 2002 | — | Q1 | — | 3,7 | — | — | — | — |
| 2001 | — | Q1 | — | 6,6 | — | — | — | — |
| 2000 | — | Q1 | — | 6,4 | — | — | — | — |
| 1999 | — | Q1 | — | 4,9 | — | — | — | — |
| 1998 | — | Q1 | — | 5 | — | — | — | — |
| 1997 | — | Q1 | — | 4,8 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | TOXICOLOGY | SCIE | Q1 | Q3 | 15/106 |
| 2024 | TOXICOLOGY | SCIE | Q1 | Q3 | 23/106 |
| 2023 | TOXICOLOGY | SCIE | Q1 | Q2 | 12/106 |
| 2022 | TOXICOLOGY | SCIE | Q1 | Q2 | 10/94 |
| 2021 | TOXICOLOGY | SCIE | Q1 | Q2 | 11/94 |
| 2020 | TOXICOLOGY | SCIE | Q1 | Q3 | 12/93 |
| 2019 | TOXICOLOGY | SCIE | Q1 | Q2 | 14/92 |
| 2018 | TOXICOLOGY | SCIE | Q1 | Q2 | 11/93 |
| 2017 | TOXICOLOGY | SCIE | Q1 | Q2 | 8/94 |
| 2016 | TOXICOLOGY | SCIE | Q1 | — | 8/92 |
| 2015 | TOXICOLOGY | SCIE | Q1 | — | 7/90 |
| 2014 | TOXICOLOGY | SCIE | Q1 | — | 7/88 |
| 2013 | TOXICOLOGY | SCIE | Q1 | — | 6/87 |
| 2012 | TOXICOLOGY | SCIE | Q1 | — | 5/85 |
| 2011 | TOXICOLOGY | SCIE | Q1 | — | 5/83 |
| 2010 | TOXICOLOGY | SCIE | Q1 | — | 12/83 |
| 2009 | TOXICOLOGY | SCIE | Q1 | — | 6/77 |
| 2008 | TOXICOLOGY | SCIE | Q1 | — | 2/75 |
| 2007 | TOXICOLOGY | SCIE | Q1 | — | 2/73 |
| 2006 | TOXICOLOGY | SCIE | Q1 | — | 7/76 |
| 2005 | TOXICOLOGY | SCIE | Q1 | — | 4/75 |
| 2004 | TOXICOLOGY | SCIE | Q1 | — | 6/75 |
| 2003 | TOXICOLOGY | SCIE | Q1 | — | 11/77 |
| 2002 | TOXICOLOGY | SCIE | Q1 | — | 5/76 |
| 2001 | TOXICOLOGY | SCIE | Q1 | — | 2/78 |
| 2000 | TOXICOLOGY | SCIE | Q1 | — | 2/77 |
| 1999 | TOXICOLOGY | SCIE | Q1 | — | 2/74 |
| 1998 | TOXICOLOGY | SCIE | Q1 | — | 2/71 |
| 1997 | TOXICOLOGY | SCIE | Q1 | — | 2/63 |